nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP3A4—Fingolimod—multiple sclerosis	0.106	0.139	CbGbCtD
Ketobemidone—CYP2C19—Prednisone—multiple sclerosis	0.0859	0.112	CbGbCtD
Ketobemidone—CYP2B6—Dexamethasone—multiple sclerosis	0.0844	0.11	CbGbCtD
Ketobemidone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0685	0.0896	CbGbCtD
Ketobemidone—CYP2C8—Dexamethasone—multiple sclerosis	0.0639	0.0835	CbGbCtD
Ketobemidone—CYP2C19—Dexamethasone—multiple sclerosis	0.0536	0.0701	CbGbCtD
Ketobemidone—CYP3A4—Triamcinolone—multiple sclerosis	0.0519	0.0679	CbGbCtD
Ketobemidone—CYP3A4—Mitoxantrone—multiple sclerosis	0.05	0.0653	CbGbCtD
Ketobemidone—CYP2C9—Dexamethasone—multiple sclerosis	0.0446	0.0583	CbGbCtD
Ketobemidone—CYP3A4—Betamethasone—multiple sclerosis	0.0446	0.0582	CbGbCtD
Ketobemidone—CYP3A4—Prednisolone—multiple sclerosis	0.044	0.0575	CbGbCtD
Ketobemidone—CYP3A4—Prednisone—multiple sclerosis	0.0415	0.0543	CbGbCtD
Ketobemidone—CYP3A4—Dexamethasone—multiple sclerosis	0.0259	0.0339	CbGbCtD
Ketobemidone—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000173	0.000735	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000173	0.000735	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000171	0.000727	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000169	0.000717	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000168	0.000715	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000167	0.00071	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000165	0.000702	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—POMC—multiple sclerosis	0.000165	0.000702	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP27B1—multiple sclerosis	0.000164	0.000699	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP24A1—multiple sclerosis	0.000164	0.000699	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000163	0.000694	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000162	0.000691	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000162	0.000687	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000161	0.000683	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000161	0.000683	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000161	0.000683	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000157	0.000669	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000157	0.000668	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000157	0.000666	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000156	0.000663	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000155	0.00066	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000155	0.000659	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000154	0.000656	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000154	0.000656	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000154	0.000655	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—RRM1—multiple sclerosis	0.000153	0.00065	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000152	0.000645	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000151	0.000641	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SRM—multiple sclerosis	0.000151	0.000641	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GPC5—multiple sclerosis	0.00015	0.000639	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00015	0.000638	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000148	0.000629	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000148	0.000627	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000146	0.000621	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000145	0.000616	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000142	0.000602	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000141	0.0006	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000141	0.0006	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00014	0.000594	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	0.00014	0.000594	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000138	0.000586	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000137	0.000584	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000136	0.000579	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000135	0.000575	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000135	0.000575	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000135	0.000574	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SRM—multiple sclerosis	0.000135	0.000572	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000133	0.000564	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000132	0.000563	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000132	0.000561	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000128	0.000545	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000127	0.000539	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	0.000125	0.000533	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	0.000125	0.000533	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000125	0.000531	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000125	0.00053	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	0.000125	0.00053	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—RRM1—multiple sclerosis	0.000125	0.00053	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000123	0.000522	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000123	0.000521	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000122	0.00052	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.00012	0.000512	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.00012	0.000509	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000119	0.000508	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000119	0.000504	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000118	0.0005	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000116	0.000494	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000115	0.000489	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GPC5—multiple sclerosis	0.000115	0.000488	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000114	0.000486	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000114	0.000486	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000114	0.000485	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000114	0.000483	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.00011	0.000467	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000108	0.000461	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000107	0.000454	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	0.000106	0.000452	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	0.000106	0.000452	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.000106	0.00045	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000106	0.000449	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000105	0.000445	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000104	0.000443	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000104	0.000441	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000104	0.000441	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000103	0.000439	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000102	0.000434	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000102	0.000433	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.000101	0.00043	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	9.94e-05	0.000423	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	9.82e-05	0.000418	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GPC5—multiple sclerosis	9.71e-05	0.000413	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.66e-05	0.000411	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	9.63e-05	0.00041	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	9.5e-05	0.000404	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—RRM1—multiple sclerosis	9.5e-05	0.000404	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	9.48e-05	0.000403	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	9.48e-05	0.000403	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	9.37e-05	0.000398	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	9.33e-05	0.000397	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.29e-05	0.000395	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	9.27e-05	0.000394	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.26e-05	0.000394	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	9.17e-05	0.00039	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PGR—multiple sclerosis	9.13e-05	0.000388	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	8.96e-05	0.000381	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	8.92e-05	0.000379	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CD28—multiple sclerosis	8.87e-05	0.000377	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	8.85e-05	0.000376	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—BCHE—multiple sclerosis	8.78e-05	0.000373	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	8.72e-05	0.000371	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	8.71e-05	0.000371	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GPC5—multiple sclerosis	8.67e-05	0.000369	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	8.64e-05	0.000368	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	8.64e-05	0.000368	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	8.47e-05	0.00036	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.45e-05	0.000359	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.3e-05	0.000353	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	8.29e-05	0.000353	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	8.26e-05	0.000351	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	8.18e-05	0.000348	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	8.14e-05	0.000346	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SRM—multiple sclerosis	8.09e-05	0.000344	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—RRM1—multiple sclerosis	8.05e-05	0.000342	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	8.04e-05	0.000342	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	8.03e-05	0.000342	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	7.92e-05	0.000337	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GPC5—multiple sclerosis	7.9e-05	0.000336	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	7.84e-05	0.000333	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PGR—multiple sclerosis	7.72e-05	0.000328	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	7.57e-05	0.000322	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.57e-05	0.000322	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	7.53e-05	0.00032	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CD28—multiple sclerosis	7.5e-05	0.000319	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.5e-05	0.000319	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	7.43e-05	0.000316	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	7.36e-05	0.000313	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	7.27e-05	0.000309	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	7.24e-05	0.000308	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CD86—multiple sclerosis	7.22e-05	0.000307	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—RRM1—multiple sclerosis	7.18e-05	0.000305	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—BCHE—multiple sclerosis	7.15e-05	0.000304	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	7.11e-05	0.000302	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	6.91e-05	0.000294	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	6.9e-05	0.000293	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	6.8e-05	0.000289	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	6.6e-05	0.000281	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	6.58e-05	0.00028	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—RRM1—multiple sclerosis	6.55e-05	0.000279	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	6.4e-05	0.000272	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CD86—multiple sclerosis	6.33e-05	0.000269	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	6.31e-05	0.000268	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	6.28e-05	0.000267	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	6.26e-05	0.000266	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.24e-05	0.000266	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	6.23e-05	0.000265	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	6.14e-05	0.000261	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	6.12e-05	0.00026	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	6.05e-05	0.000257	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APOE—multiple sclerosis	5.83e-05	0.000248	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	5.77e-05	0.000245	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.7e-05	0.000242	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.7e-05	0.000242	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	5.61e-05	0.000239	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	5.58e-05	0.000237	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.57e-05	0.000237	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	5.53e-05	0.000235	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	5.49e-05	0.000234	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—BCHE—multiple sclerosis	5.46e-05	0.000232	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.36e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CD86—multiple sclerosis	5.35e-05	0.000228	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—APOE—multiple sclerosis	5.28e-05	0.000225	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	5.27e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CD80—multiple sclerosis	5.27e-05	0.000224	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.21e-05	0.000222	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	5.11e-05	0.000217	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APOE—multiple sclerosis	5.11e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.08e-05	0.000216	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—POMC—multiple sclerosis	5e-05	0.000213	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	4.9e-05	0.000208	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.89e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	4.88e-05	0.000207	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	4.79e-05	0.000204	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.79e-05	0.000204	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	4.75e-05	0.000202	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	4.68e-05	0.000199	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	4.64e-05	0.000197	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—BCHE—multiple sclerosis	4.62e-05	0.000197	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CD80—multiple sclerosis	4.62e-05	0.000196	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—POMC—multiple sclerosis	4.54e-05	0.000193	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	4.45e-05	0.000189	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—POMC—multiple sclerosis	4.39e-05	0.000187	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.36e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.36e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.32e-05	0.000184	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APOE—multiple sclerosis	4.32e-05	0.000184	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—APOE—multiple sclerosis	4.3e-05	0.000183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	4.29e-05	0.000183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	4.2e-05	0.000179	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALB—multiple sclerosis	4.14e-05	0.000176	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—BCHE—multiple sclerosis	4.13e-05	0.000175	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.98e-05	0.000169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CD80—multiple sclerosis	3.9e-05	0.000166	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	3.9e-05	0.000166	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.76e-05	0.00016	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—POMC—multiple sclerosis	3.71e-05	0.000158	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—multiple sclerosis	3.7e-05	0.000157	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—POMC—multiple sclerosis	3.7e-05	0.000157	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	3.68e-05	0.000157	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	3.63e-05	0.000154	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	3.55e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	3.5e-05	0.000149	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—multiple sclerosis	3.37e-05	0.000143	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	3.3e-05	0.00014	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOE—multiple sclerosis	3.28e-05	0.00014	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—multiple sclerosis	3.24e-05	0.000138	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	3.23e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	3.11e-05	0.000132	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	3.07e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—multiple sclerosis	2.89e-05	0.000123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	2.89e-05	0.000123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	2.83e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—POMC—multiple sclerosis	2.82e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOE—multiple sclerosis	2.78e-05	0.000118	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—multiple sclerosis	2.74e-05	0.000117	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	2.73e-05	0.000116	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	2.73e-05	0.000116	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	2.59e-05	0.00011	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—multiple sclerosis	2.57e-05	0.000109	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—multiple sclerosis	2.54e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	2.53e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	2.48e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOE—multiple sclerosis	2.48e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.48e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—POMC—multiple sclerosis	2.39e-05	0.000102	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	2.31e-05	9.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOE—multiple sclerosis	2.26e-05	9.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—multiple sclerosis	2.18e-05	9.26e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—multiple sclerosis	2.17e-05	9.25e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—multiple sclerosis	2.14e-05	9.12e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	2.14e-05	9.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—POMC—multiple sclerosis	2.13e-05	9.07e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	2.1e-05	8.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—POMC—multiple sclerosis	1.94e-05	8.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—multiple sclerosis	1.94e-05	8.27e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.91e-05	8.11e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—multiple sclerosis	1.77e-05	7.54e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—multiple sclerosis	1.61e-05	6.85e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOE—multiple sclerosis	1.49e-05	6.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.28e-05	5.45e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—multiple sclerosis	1.17e-05	4.97e-05	CbGpPWpGaD
